Managing Clopidogrel Hypersensitivity without Interrupting Therapy: The Toronto Approach

Area of Science:

• Cardiology
• Pharmacology
• Immunology

Background:

• Clopidogrel is a vital antiplatelet medication for atherothrombotic disease patients.
• Clopidogrel hypersensitivity is an infrequent but recognized adverse drug reaction.
• Managing hypersensitivity poses a clinical challenge, impacting treatment decisions.

Purpose of the Study:

• To review the phenomenon of clopidogrel hypersensitivity.
• To discuss various clinical presentations of clopidogrel hypersensitivity.
• To outline current and potential treatment strategies for clopidogrel hypersensitivity.

Main Methods:

• Literature review of clopidogrel hypersensitivity.
• Analysis of clinical presentations and adverse events.
• Evaluation of treatment options including discontinuation, desensitization, and alternative therapies.

Main Results:

• Clopidogrel hypersensitivity manifests variously, from skin reactions to systemic responses.
• Treatment decisions depend on clinical presentation and patient risk.
• Management strategies include drug cessation, desensitization, or alternative antiplatelet agents.

Conclusions:

• Clopidogrel hypersensitivity requires careful patient management.
• A range of therapeutic options exist, tailored to individual patient needs.
• Further research may refine management protocols for clopidogrel hypersensitivity.